Primary outcome
Diabetic Retinopathy
DIABETIC RETINOPATHY
In the intention-to-treat population, the mean change in best-corrected visual acuity (BCVA) measured as the Early Treatment Diabetic Retinopathy Study (ETDRS) score from baseline to week 26 was 11.2 letters (95% confidence interval [CI], 7.5–14.9) in the immunosuppressant group, as compared with 6.3 letters (95% CI, 3.1–9.6) in the biologic group (difference, 4.9; 95% CI, 0.2–9.5; one-sided 